Showing results (541-550 of 2,503) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|March 7, 2025
Revisiting the causal impact of lipid traits on metabolic dysfunction-associated fatty liver disease: Insights from a multidimensional plasma lipid profileFang Xie, Wenkai Zheng, Jing Chen, et al.Journal of Diabetes Investigation|March 4, 2025
Ginsenoside Rg1 inhibits angiogenesis in diabetic retinopathy through the miR-100-3p/FBXW7/c-MYC molecular axisLiping Xue, Min Hu, Yadi Li, et al.Journal of Diabetes Investigation|June 14, 2024
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims databaseRyoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, et al.Journal of Diabetes Investigation|July 24, 2024
Efficacy of long-term low carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysisTakahiro Ichikawa, Hiroshi Okada, Junya Hironaka, et al.Journal of Diabetes Investigation|July 15, 2024
Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort studyXueqi Bai, Qingyi Zhu, Wenli Wang, et al.Journal of Diabetes Investigation|May 22, 2024
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLDDaisuke Ito, Satoshi Shimizu, Akifumi Haisa, et al.Journal of Diabetes Investigation|May 15, 2024
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitusPannipa Suwannasom, Tasalak Thonghong, Krit Leemasawat, et al.Journal of Diabetes Investigation|June 26, 2024
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patientsJingyi Zhong, Xiaopu Lin, Xiaobin Zheng, et al.Journal of Diabetes Investigation|June 14, 2024
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed miceOsamu Kikuchi, Yuichi Ikeuchi, Masaki Kobayashi, et al.Journal of Diabetes Investigation|December 24, 2025
Advances in insulin pump systems lead to stepwise improvements in treatment satisfaction in people with type 1 diabetes: A single-center retrospective studyNaoya Shimizu, Nozomi Ishimoto, Umeko Sakamoto, et al.Pageof 251